Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity
Author(s) -
Stéphanie Struski,
Martine DocoFenzy,
Michael Köehler,
Ilse Chudoba,
F. Lévy,
Linda Masson,
Nicole Michel,
Evelyne Ulrich,
Nadine Gruson,
Jean Bénard,
G Potron,
Pascale CornilletLefèbvre
Publication year - 2003
Publication title -
analytical cellular pathology
Language(s) - English
Resource type - Journals
eISSN - 2210-7185
pISSN - 2210-7177
DOI - 10.1155/2003/151042
Subject(s) - karyotype , chromosomal translocation , biology , comparative genomic hybridization , cancer research , cell culture , phenotype , gene duplication , reversion , genetics , metaphase , multiple drug resistance , chromosome , drug resistance , gene
In order to identify genomic changes associated with a resistant phenotype acquisition, we used comparative genomic hybridization (CGH) to compare a human ovarian cell line, Igrov1, and four derived subcell lines, resistant to vincristine and presenting a reversion of malignant properties. Multicolor FISH (Multiplex-FISH and Spectral Karyotype) and conventional FISH are also used to elucidate the karyotype of parental cell line. The drug-resistant subcell lines displayed many chromosomal abnormalities suggesting the implication of different pathways leading to a multidrug resistance phenotype. However, these cell lines shared two common rearrangements: an unbalanced translocation der(8)t(8;13)(p22;q?) and a deletion of the 11p. These chromosomal imbalances could reflected the acquisition of the chemoresistance (der(8)) or the loss of tumorigenicity properties (del(11p)).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom